ALS News Today Forums › Forums › Flash Briefings › Orphazyme Partnership Is Scheduled To Run Through The Extension of a Phase 3 Arimoclomol Study

  • Flash Briefings

    Orphazyme Partnership Is Scheduled To Run Through The Extension of a Phase 3 Arimoclomol Study

    Posted by ALS News Today Moderator on October 3, 2019 at 9:22 am

    ALS News Today’s forums moderator, Amanda Sifford, discusses how an Orphazyme partnership is scheduled to run through the extension of a phase 3 Arimoclomol study.

    Are you interested in learning more about ALS? If so, please visit alsnewstoday.com/

    What do you think about this news? Listen to this episode and share your thoughts on the comment section below.

    ALS News Today Moderator replied 4 years, 6 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .